cysteine has been researched along with Respiration Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Zeev, B; Carroll, JL; Cilio, MR; Cooper, EC; Grønborg, S; Jiang, YH; Joshi, N; Kelly, M; Koolen, DA; Mikati, MA; Mulkey, SB; Nicolai, J; Park, K; Pearl, PL; Scheffer, IE; Spillmann, RC; Taglialatela, M; Vieker, S; Weckhuysen, S | 1 |
| Chernyshov, VP; Gumenyuk, ME; Omelchenko, LI; Pochinok, TV; Treusch, G; Vodyanik, MA; Zelinsky, GM | 1 |
| HERNALSTEEN, L | 1 |
3 other study(ies) available for cysteine and Respiration Disorders
| Article | Year |
|---|---|
Neonatal nonepileptic myoclonus is a prominent clinical feature of KCNQ2 gain-of-function variants R201C and R201H.
Topics: Anticonvulsants; Arginine; Child, Preschool; Cysteine; Electroencephalography; Female; Histidine; Humans; Infant; Infant, Newborn; KCNQ2 Potassium Channel; Magnetic Resonance Imaging; Male; Myoclonus; Phenotype; Polymorphism, Single Nucleotide; Registries; Respiration Disorders; Spasms, Infantile | 2017 |
Up-regulation of interferon-gamma production by reduced glutathione, anthocyane and L-cysteine treatment in children with allergic asthma and recurrent respiratory diseases.
Topics: Adjuvants, Immunologic; Adolescent; Anthocyanins; Asthma; Child; Cysteine; Drug Combinations; Female; Glutathione; Humans; Interferon-gamma; Lipopolysaccharides; Male; Monocytes; Respiration Disorders; Up-Regulation | 2002 |
[Anti-inflammatory property of a cysteine derivative on the respiratory mucous membranes].
Topics: Anti-Inflammatory Agents; Cysteine; Disease; Humans; Respiration Disorders; Respiratory Mucosa; Respiratory System; Respiratory Tract Diseases | 1961 |